To: Profiteer who wrote (427 ) 5/26/1998 5:27:00 PM From: Gwolf Read Replies (5) | Respond to of 6039
To All: CTI is in a Phase 3 trial. This trial is a Double "BLIND" study. I highlight blind because this is exactly what the participants are, blind to all of the information being gathered. CTI only sees the information they gather, They do not see the info on the mammograms, They do not see the results of the Biopsies. The Doctors are not permitted to know CTI's results, they do of course know the results of the biopsy so they can assist the patient. The people conducting the mammograms don't get any information other than their own results. The doctors are only allowed to confirm that a clinical trial is in process. ONLY the FDA will be able to see all of the information. This is the Data Collection step. The next step is Data Analysis. In data analysis the have to evaluate how the Doctor would interpret and evaluate the data from CTI. They would present the mammogram only data to a group of doctors and see what their diagnosis would be. They then would take the same case studies and present it to a different set of doctors and see what their diagnosis would be using the information from CTI process. This all takes place after the data collection is complete. Once they have the CTI data, mammogram data, biopsy data, data analysis and doctor evaluation it is then submitted in a seperate filing for approval. My point of this long explanation is that you can call everyone associated with this whole process and you will not be able to find out what's going on because no one person or affliation will know other than the FDA. Everyone wants to know what is going on with the company but at the same time they don't want any hype. That's very interesting. If the company is in talks with someone about a potential sale and they tell all the shareholders about it and then it never comes to pass wouldn't that look like they were just hyping the company. If you look at the press releases of most companies you will see that they generally create a news release on some material fact after it has been consumated. Usually they only comment on something other than a done deal if it hits the news prematurely and then they are usually requested to do so by the exchange or the NASDAQ. So when is it news and when is it hype. If nothing has actually occured and they are just working on something then the only thing they can tell us is about something they think will happen in the future. That is a forward looking statement which they can not do. I don't know who peoples inside sources are but if it is not coming directly from the company then I would be suspicous as to it's nature. There are people who are close to the company that may see things in process who comment on this, but remember one thing, a deal in process does not make it a done deal. Deals get postponed, delayed and outright canceled. What's that old saying don't count your chickens before they're hatched. David Packer told us all that he would try to let us know what was going on as best he could during the quite period. When this whole thing came up with the registration statement he responded in a timely fashion and let us know what was going on. The only thing he can tell us now would be things they are working on that may or may not pan out.So do we wait for validate news or do we just want to hear what some people consider hype. We can't have it both ways you know. For those of you that don't speak Propectorese - Wireson is the Market Makers, they are the only bad guys that can be identified, there is no one actively trying to talk the stock down, so it's the MM's. Dr. Dave and Peter, welcome to the site. Dr. Dave any information that you come across please let us know. The more information that we can find out the better. Dr. White glad to see that you're still here and asking questions. I think that is invaluable for us on the thread to have you gentlemen with medical experience conversing and asking questions.We lay folk need your medical knowledge.